Aims There are limited and contradictory data on the effects of CRT with implantable
cardioverter defibrillator (CRT‐D) on mortality as compared with CRT with pacemaker (CRT …

Aims Cardiac resynchronization therapy (CRT) with or without a defibrillator reduces
morbidity and mortality in selected patients with heart failure (HF) but response can be …

Background Studies of cardiac resynchronization therapy in addition to an implantable
cardioverter defibrillator in patients with mild to moderate congestive heart failure had not …

Aims Primary prevention of sudden cardiac death (SCD) in non-ischemic heart failure (HF)
patients remains a topic of debate at cardiac resynchronization therapy (CRT) implantation …

Background: Trials comparing implantable cardioverter-defibrillator (ICD) therapy with
cardiac resynchronization therapy with a defibrillator (CRT-D) are limited to selected patients …

Aims Mortality and ventricular arrhythmias are reduced in patients responding to cardiac
resynchronization therapy (CRT). This response is accompanied by improvement in LVEF …

Objectives: The goal of this study was to evaluate the influence of left ventricular (LV) lead
position on the risk of ventricular tachyarrhythmia in patients undergoing cardiac …

To date, 3 placebo control studies have been published, as follows: PAcing THerapies for
Congestive Heart Failure (PATH-CHF), MUltisite STimulation In Cardiomyopathy (MUSTIC) …

Background: Cardiac resynchronisation therapy (CRT) improves outcomes in selected
patients with heart failure and left ventricular dysfunction. One mechanism of benefit is …

BACKGROUND: Few studies have directly compared cardiac resynchronisation therapy
(CRT) with combined CRT-cardioverter defibrillator therapy (CRT-D) in patients with left …